Dhanuka Agritech Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2026.
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.4 pts more than Nifty Microcap 250 and 7.2 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dhanuka Agritech reported FY2026 audited results with revenue from operations at Rs 2,02,0 lakhs, marginally lower than Rs 2,03,515 lakhs in FY2025. Profit after tax declined 3.3% to Rs 28,723 lakhs from Rs 29,696 lakhs, with basic EPS at Rs 63.72 versus Rs 65.55. The Board approved a share buyback of up to 5 lakh equity shares at Rs 1,400 per share for Rs 70 crore (1.11% of capital). A final dividend of Rs 2 per share (100%) was recommended. The company also approved ESOP 2026 (50,000 options) and SAR 2026 (1,25,000 rights), subject to shareholder approval. Plans to set up wholly owned subsidiaries in Brazil and Europe (initially Rs 1 crore each) were approved to support international expansion of Bayer-acquired brands. Statutory auditors gave an unmodified (clean) opinion.
While revenue and PAT showed marginal declines, the Rs 70 crore buyback at Rs 1,400 per share signals management confidence and provides direct return to shareholders. The clean audit and dividend recommendation are positives. Expansion into Brazil and Europe through WOS could drive long-term growth.